Balyasny Asset Management LLC Immunocore Holdings PLC Transaction History
Balyasny Asset Management LLC
- $58 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding IMCR
# of Institutions
135Shares Held
40.8MCall Options Held
197KPut Options Held
451K-
Wellington Management Group LLP Boston, MA7.05MShares$205 Million0.04% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.5MShares$189 Million0.12% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$141 Million2.42% of portfolio
-
Primecap Management CO Pasadena, CA2.47MShares$71.7 Million0.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.16MShares$62.6 Million0.01% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.27B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...